Galena Biopharma (GALE) Reports In-Line Q3 Loss of 9c/Share

Galena Biopharma (NASDAQ: GALE) reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
• UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters